Anthrax Infection
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines (NCT01979406) | Emergent BioSolutions | 2013-11-01 |
Track Anthrax Infection automatically
Every clearance here is in the API, with alerts when new ones post.